Vitalab Plus ApS: Financial statements 2025
CVR: 44060809
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Vitalab Plus ApS (CVR 44060809) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 35,537 and a net result of DKK -6,040 compared with DKK -3,362 the year before. The profit margin was -17%. Equity in the 2025 report amounted to DKK 20,897. The solvency ratio was 74.7%.
- Revenue
- DKK 35,537
- Gross Profit
- DKK 3,626
- Profit/Loss
- DKK -6,040
- Equity
- DKK 20,897
- Total Assets
- DKK 27,963
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 36 t. | 4 t. | -6 t. | 21 t. | - |
| 2024 | - | -5 t. | -3 t. | 27 t. | 1 |
Official annual report
How creditworthy is Vitalab Plus ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Vitalab Plus ApS has published its annual report for 2024. Gross profit came to DKK -5,251, and the net result was DKK -3,362.
About Vitalab Plus ApS
Vitalab Plus ApS is a Danish company of the type Anpartsselskab based in Valby, founded in 2023. The company is registered under the industry Detailhandel med farmaceutiske produkter. The management consists of Sami Mostafa. The company is owned by Samara Holding ApS. According to the 2024 annual report, the company had an average of 1 employee. In 2025, the company reported revenue of DKK 35,537 and a net result of DKK -6,040 compared with DKK -3,362 the year before. Equity in the 2025 report amounted to DKK 20,897.